Astragalus membranaceus infusion effect on rats learning in the radial maze

Cover Page

Cite item

Abstract

Relevance. Treatment of cognitive impairment is a serious problem for modern medicine. Alzheimer’s disease and Parkinson’s disease are chronic progressive neurodegenerative diseases and the most common cause of progressive dementia in the elderly. There is no effective therapy for these diseases, so it is necessary to search for integrated therapies, including herbal medicine. The aim was to study a short-term and long-term memory of rats in the test «eight-arm radial maze» under the infl of repeated administration of an aqueous extract of the herb Astragalus membranaceus (Fisch.) Bunge. Materials and Methods. The experiment was carried out on 18 non-linear rats, divided into 3 groups - control and 2 experimental. For 21 days, the animals received daily intragastric caffeine at a dose of 5 mg/kg, infusion an aqueous extract of Astragalus membranaceus (Fisch.) Bunge at a dose of 100 mg/kg. The control was injected with drinking water by weight. To study the cognitive functions of the maze, performing two series of tests - at 2-7 and 16-21. Results and Discussion. In the course of the study, it was found that when the animals were tested for 2-7 days, there were no signifi changes between the groups. With an increase in the duration of administration of the test substances by the 16-21 days of the experiment, in the second test series, an increase in memory points was observed both in the second (caffeine, 5 mg/kg) and in the third ( Astragalus membranaceus (Fisch.) Bunge, 100 mg/kg) of the experimental groups. Conclusion. The introduction of caffeine at a dosage of 5 mg/kg infl d the activation of short-term and long-term memory with a duration of more than 17 days of administration - at the 2nd stage of testing. Astragalus membranaceus (Fisch.) Bunge (100 mg/kg) caused the activation of working and long-term spatial memory from the 16th day of the experiment - on the 2nd series of tests.

About the authors

Alena Yu. Karetnikova

Saratov State Medical University

Email: ndurnova@mail.ru
ORCID iD: 0000-0002-8043-3142
Saratov, Russian Federation

Uliana A. Matvienko

Saratov State Medical University

Email: ndurnova@mail.ru
ORCID iD: 0000-0002-1714-9165
Saratov, Russian Federation

Daria A. Savinova

Saratov State Medical University

Email: ndurnova@mail.ru
ORCID iD: 0000-0001-7825-3620
Saratov, Russian Federation

Elvira A. Denikaeva

Saratov State Medical University

Email: ndurnova@mail.ru
ORCID iD: 0000-0002-4954-4717
Saratov, Russian Federation

Natalya A. Durnova

Saratov State Medical University

Author for correspondence.
Email: ndurnova@mail.ru
ORCID iD: 0000-0003-4628-9519
Saratov, Russian Federation

References

  1. May BH, Lit M, Xue C, Yang A.W, Zhang AL, Owens MD, Head R, Cobiac L, Li CG, Hugel H, Story DF. Herbal medicine for dementia: a systematic review. Phytother Res. 2009;23(4):447—59. doi: 10.1002/ptr.2656
  2. Tohda C, Tamura T, Matsuyama S, Komatsu K. Promotion of axonal maturation and prevention of memory loss in mice by extracts of Astragalus mongholicus. Br J Pharmacol. 2006;149(5):532—41.
  3. Xie A, Gao J, Xu L, Meng D. Shared mechanisms of neurodegeneration in Alzheimer’s disease and Parkinson’s disease. BioMed Research International. 2014;14:1—8. doi: 10.1155/2014/648740
  4. Orlov MA. Alzheimer’s disease therapy: challenges and perspectives. Advances in Gerontology. 2019;32(4):639—651 (In Russian).
  5. Bachurin SO, Bovina EV, Ustyugov AA. Drugs in clinical trials for Alzheimer’s disease: the major trends. Medicinal research reviews. 2017;37(5):1186—1225.
  6. DeFina PA, Moser RS, Glenn M, Lichtenstein JD, Fellus J. Alzheimer’s disease clinical and research update for health care practitioners. J Aging Res. 2013;2013:207178. doi: 10.1155/2013/207178
  7. Howes MJR, Perry NS, Houghton PJ. Plants with traditional uses and activities, relevant to the management of Alzheimer’s disease and other cognitive disorders. Phytother Res. 2003;17:1—18.
  8. Perry NS, Bollen C, Perry EK, Ballard C. Salvia for dementia therapy: Review of pharmacological activity and pilot tolerability clinical trial. Pharmacol Biochem Behav. 2003;75:651—659.
  9. Berezutsky MA, Durnova N, Andronova TA, Sinichkina OV. Alzheimer’s disease: experimental and clinical researches of chinese herbal medicine neurobiological effects (a review). Advances in Gerontology. 2020;33(2):273—281 (in Russian).
  10. Zhou R, Chen H, Chen J, Chen X, Wen Y, Xu L. Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K/AKT/mTOR signaling pathway. BMC Complement Altern Med. 2018;18(1):83. doi: 10.1186/s12906-018-2148-2
  11. Bedir E, Pugh N, Calis I, Pasco DS, Khan IA. Immunostimulatory effects of cycloartane-type triterpene glycosides from Astragalus species. Biological and Pharmaceutical Bulletin. 2000;23(7):834—837.
  12. Chan WS, Durairajan SS, Lu JH, Wang Y, Xie LX, Kum WF, Kooa I, Yung KKL, Li M. Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture. Neurochemistry International. 2009;55(6):414—422.
  13. Choi HS, Joo SJ, Yoon HS, Kim KS, Song IG, Min KB. Quality characteristic of Hwangki (Astragalus membranaceus) Chungkukjang during fermentation. Korean Journal of Food Preservation. 2007;14(4):356—363.
  14. Park HJ, Park SH. Induction of Apoptosis by Ethyl Acetate Fraction of Astragalus membranaceus in Human Nonsmall Cell Lung Cancer Cells: Apoptosis Induction by Astragalus membranaceus. J. Pharmacopuncture. 2018;21(4):268—276.
  15. Fu J, Wang Z, Huang L, Zheng S, Wang D, Chen S, Zhang H, Yang S. Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi). Phytother Res. 2014;28(9):1275—83. doi: 10.1002/ptr.5188
  16. Shi R, He L, Hu Y, Yi N, Weng S, Cao YJ. The regulatory action of Radix Astragali on M-cholinergic receptor of the brain of senile rats. Tradit Chin Med. 2001;21(3):232—5.
  17. Huang F, Xue W, Lan Yu, Tao Y, Zhou J, Yang L, Guan H, Zhang X, Wu X, Hu Z. Astragaloside IV suppressed hippocampal GABAergic synaptic transmission and enhanced memory through EGR-1 mediated BDNF/TrkB signaling pathway in mice. Research Square. 2020. doi: 10.21203/rs.3.rs-35057/v2
  18. State Pharmacopoeia of the Russian Federation. XIV ed. 1. MZ RF. Moscow. 2018. 1814 p.
  19. Prozorovsky VB. Using the least squares method for probit analysis of mortality curves. Pharmacol. and toxicol. 1962;25(1):115— 120 (In Russian).
  20. Iptyshev AM, Gorina YaV, Lopatina OL, Komleva YuK, Chernykh AI, Belova OA, Salmina AB. Comparison of the eight-arm radial maze and Morris water maze tests in assessing spatial memory in experimental animals during neurobehavioral testing. Fundamental and Clinical Medicine. 2017;2(2):62—68 (In Russian).
  21. Arushanyan EB, Popov AV. Features of the temporal organization of behavioral rats on caffeine. Eksperimentalnaya i Klinicheskaya Farmakologiya. 2005;68(1):10—12 (In Russian).
  22. Alzoubi KH, Mhaidat NM, Obaid EA, Khabour OF. Caffeine Prevents Memory Impairment Induced by Hyperhomocysteinemia. J Mol Neurosci. 2018;66(2):222—228. doi: 10.1007/s12031-0181158-3

Copyright (c) 2022 Karetnikova A.Y., Matvienko U.A., Savinova D.A., Denikaeva E.A., Durnova N.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies